Report Highlights
The global patient engagement solutions market should reach $33.0 billion by 2026 from $22.4 billion in 2022 at a compound annual growth rate (CAGR) of 10.1% for the forecast period of 2022 to 2026.
Report Includes
- 30 data tables and 19 additional tables
- An overview of the global market for patient engagement solutions
- Estimation of the market size and analyses of global market trends, with data from 2020 to 2021, estimates for 2022, with projections of compound annual growth rates (CAGRs) through 2026
- Detailed insights into factors driving and restraining the growth of the global patient engagement solutions market and a country-level market value analysis for each segment
- Highlights of the market potential for patient engagement solutions, along with global market share analysis on the basis of type, application and region
- Coverage of certification commission for healthcare information technology and regulatory scenario of healthcare IT across different regions
- Information on market opportunities, prospects and threats, new and upcoming technologies, regulatory developments, and demographic shifts that are affecting the market
- Market share analysis of the key companies of the industry and coverage of their proprietary technologies, strategic alliances, and other key market strategies
- Comprehensive company profiles of the leading players of the industry, including Allscripts Healthcare Solutions Inc., Cerner Corp., Health Catalyst and McKesson Corp.
Report Scope
This report will focus on patient engagement solutions and systems. These solutions can be used in fitness health management, home health management, financial management and others. The report will portray the trends and dynamics affecting the market. The report also covers market projections to 2026, and company profiles. By geography, the market has been segregated into North America, Europe, Asia-Pacific, Middle East and Africa, and South America. The North America region includes the U.S., Canada and Mexico; Europe includes Germany, the U.K., France, Italy, Spain, and Rest of Europe; Asia-Pacific includes China, India, Japan, and Rest of Asia-Pacific. For market estimates, data have been provided for 2019 as historic year information, 2020 as the base year, for 2021 and forecast for 2026.
Report Synopsis
| Report Metrics | Details | ||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Base year considered | 2020 | ||||||||||||||||||
| Forecast period considered | 2026 | ||||||||||||||||||
| Base year market size | $18.6 billion | ||||||||||||||||||
| Market size forecast | $33.0 billion | ||||||||||||||||||
| Growth rate | CAGR of 10.1% for the forecast period of 2021-2026 | ||||||||||||||||||
| Units considered | $ Millions | ||||||||||||||||||
| Segments covered | type, application, and region. | ||||||||||||||||||
| Regions covered | North America, Europe, Asia-Pacific, Middle East and Africa, and South America | ||||||||||||||||||
| Countries covered | U.S., Canada, Mexico, U.K., France, China, India, Japan, South Korea | ||||||||||||||||||
| Key Market Drivers |
|
||||||||||||||||||
| Companies studied |
|
Analyst Credentials
BCC Research Team possesses expertise and experience in life and physical science domains. They specialize in offering valuable business insights, including industry analysis, competitor intelligence, strategic and financial analysis, and opportunity assessment. The team has in-depth knowledge of various sectors, including healthcare, biotechnology, pharmaceuticals, IT, automation, advanced materials, and energy. They are proficient in qualitative and quantitative market intelligence providing clients with actionable insights. With a vast understanding of the competitive landscape, the team can support clients in making data-driven decisions to help them achieve a competitive edge in their respective markets.
- Bioprocess Optimization and Digital Bio-manufacturing: Global Markets (BIO170B)
- Metal-organic Frameworks: Global Markets (AVM200B)
- Laboratory Animal Models, 3D Cultures, and Organoids: Global Markets (PHM204C)
- Global DNA Sequencing: Research, Applied and Clinical Markets (BIO045J)
- Surgical Equipment: Technologies and Global Markets (HLC154C)
Related Reports
Global Markets for Telemedicine Technologies
The global market for telemedicine technologies is estimated to increase from $72.4 billion in 2022 to reach $173.3 billion by 2027, with a compound annual growth rate (CAGR) of 19.1% from 2022 through 2027.
Healthcare Information Technology
The global healthcare information technology (IT) market is estimated to grow from $94.5 billion in 2021 to reach $172.3 billion by 2026 at a compound annual growth rate (CAGR) of 12.8% during the forecast period of 2021-2026.
Blockchain: Global Markets
The global blockchain market should reach $56.7 billion by 2026 from $6.0 billion in 2021 at a compound annual growth rate (CAGR) of 56.9% for the forecast period of 2021 to 2026.
How Healthcare Uses Blockchain
The goals of this study were to understand the current market scenario for Blockchain technology in Healthcare and to access the market’s growth potential over the five-year period from 2018 through the end of 2023. The study explores market dynamics such as drivers, restraints, opportunities and trends that impact the growth of the market. The main objective of the study is to present a comprehensive analysis of the current market for Blockchain technology and the future direction of the market in healthcare.
Recent Reports
Surgical Equipment: Technologies and Global Markets
The global market for surgical equipment and technologies was valued at $37.6 billion in 2023. This market is expected to grow from $40.0 billion in 2024 to $56.6 billion by 2029, at a compound annual growth rate (CAGR) of 7.2% from 2024 to 2029.
Conventional and Alternative Pain Treatment Markets
The global market for conventional and alternative pain treatment is expected to grow from $96.2 billion in 2024 and is projected to reach $144.2 billion by the end of 2029, at a compound annual growth rate (CAGR) of 8.4% during the forecast period of 2024 to 2029.
CRISPR Technology: Global Markets
The global market for CRISPR technology was valued at $3.4 billion in 2023. This market is expected to grow from $3.8 billion in 2024 to $7.5 billion by the end of 2029, at a compound annual growth rate (CAGR) of 14.4% from 2024 to 2029.
Chronic Disease Management: Therapeutics, Device Technologies and Global Markets
The global market for chronic disease management therapeutics and device technologies was valued at $675.0 billion in 2023. It is projected to grow from $726.3 billion in 2024 to $1.1 trillion by 2029, at a compound annual growth rate (CAGR) of 8.1% from 2024 through 2029.
Medical Devices: Technologies and Global Markets
The global market for medical devices reached $739.6 billion in 2023. It is expected to grow from $810.4 billion in 2024 to $1.3 trillion by the end of 2029, at a compound annual growth rate (CAGR) of 9.8% from 2024 through 2029.
Top Trending Reports
Single-use Technologies for Biopharmaceuticals: Global Markets
The global market for single-use technologies for biopharmaceuticals is expected to grow from $6.5 billion in 2024 and is projected to reach $11.2 billion by the end of 2029, at a compound annual growth rate (CAGR) of 11.6% during the forecast period of 2024 to 2029.
Cell and Gene Therapy Tools, and Reagents: Global Markets
The global market for Cell and Gene Therapy (CGT) Tools and Reagents is estimated to increase from $10.0 billion in 2024 to reach $16.7 billion by 2029, at a compound annual growth rate (CAGR) of 10.8% from 2024 through 2029.
Medical Devices Industry: Competitive Landscape
The global market for medical devices is estimated to increase from 810.4 billion in 2024 to reach $1.3 trillion by 2029, at a compound annual growth rate (CAGR) of 9.8% from 2024 through 2029.
Global Market Opportunities and Competitive Landscape for CDMO
The global CDMO market was valued at $128.0 billion in 2023. This market is expected to grow from $136.6 billion in 2024 to $191.6 billion by the end of 2029, at a compound annual growth rate (CAGR) of 7.0% from 2024 to 2029.
Chronic Disease Management: Therapeutics, Device Technologies and Global Markets
The global market for chronic disease management therapeutics and device technologies was valued at $675.0 billion in 2023. It is projected to grow from $726.3 billion in 2024 to $1.1 trillion by 2029, at a compound annual growth rate (CAGR) of 8.1% from 2024 through 2029.
Become A Member
BCC Research offers a comprehensive library of reports, granting members unlimited access to data, insights, and market intelligence for informed business decisions, while actively supporting members in their evolving journeys and prioritizing high-quality, relevant topics based on continuous engagement with the research community.
Find Out MoreCustom Consulting
BCC Research emphasizes the importance of organizations leveraging highly customized market insights aligned with specific strategic business objectives through direct engagement with primary sources and proprietary forecasting models for profitable decision-making in maximizing growth opportunities and minimizing risks.
Customize NowScorecard
The Venture Scorecard provides commercialization offices and decision makers with expert analysis, offering strategic insights crucial for aligning objectives with market realities at various stages of commercializing new products or evaluating investment opportunities, from opportunity assessment to growth planning.
Find Out MoreInnovation Spotlight
Our industry experts offer strategic guidance to maximize the market potential of commercialized products, patents, and IP by providing insights into market trends, competitive dynamics, and effective positioning, using the Innovation Spotlight service for enhanced exposure to thought leaders and the wider community.
Find Out More